Mammographic features associated with interval breast cancers in screening programs
暂无分享,去创建一个
N. Boyd | Lisa J. Martin | M. Yaffe | S. Minkin | E. Huszti | Olga Melnichouk | G. Hislop | A. Chiarelli | L. Martin
[1] Joann G Elmore,et al. Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography. , 2014, Radiology.
[2] T. To,et al. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial , 2014, BMJ : British Medical Journal.
[3] D. Kopans. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial: Miller AB, Wall C, Baines CJ, et al (Univ of Toronto, Ontario, Canada; et al) BMJ 348:g366, 2014§ , 2014 .
[4] X. Castells,et al. Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain , 2014, Breast Cancer Research.
[5] H. Nelson,et al. Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[6] Timothy J Wilt,et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[7] D. Petitti,et al. Responses to USPSTF Guideline on Aspirin for Prevention of Cardiovascular Disease , 2009 .
[8] Anne M Kavanagh,et al. Tumour Size at Detection According to Different Measures of Mammographic Breast Density , 2009, Journal of medical screening.
[9] Neb Duric,et al. Detection and characterization of breast masses with ultrasound tomography: clinical results , 2009, Medical Imaging.
[10] Anne M Kavanagh,et al. Using Mammographic Density to Improve Breast Cancer Screening Outcomes , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] E. Simpson,et al. Characterisation of aromatase expression in the human adipocyte cell line SGBS , 2008, Breast Cancer Research and Treatment.
[12] N. Boyd,et al. Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.
[13] F. O'Malley,et al. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000 , 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[14] R. Birdwell,et al. Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2006 .
[15] C. D'Orsi,et al. Diagnostic Performance of Digital Versus Film Mammography for Breast-Cancer Screening , 2005, The New England journal of medicine.
[16] Constantine Gatsonis,et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging , 2005, Cancer.
[17] Daniel J Brotman,et al. In search of fewer independent risk factors. , 2005, Archives of internal medicine.
[18] Mary Wilson,et al. Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study , 2004, BMJ : British Medical Journal.
[19] T. Sellers,et al. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States) , 2000, Cancer Causes & Control.
[20] D. Miglioretti,et al. Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography , 2003, Annals of Internal Medicine.
[21] Beth A Reboussin,et al. Postmenopausal hormone therapy and change in mammographic density. , 2003, Journal of the National Cancer Institute.
[22] W. Boon,et al. Aromatase--a brief overview. , 2002, Annual review of physiology.
[23] C R Key,et al. Biologic characteristics of interval and screen-detected breast cancers. , 2000, Journal of the National Cancer Institute.
[24] Anne M Kavanagh,et al. Hormone replacement therapy and accuracy of mammographic screening , 2000, The Lancet.
[25] A. Kavanagh,et al. Monitoring interval cancers in an Australian mammographic screening programme , 1999, Journal of medical screening.
[26] S. Duffy,et al. Mammographic parenchymal patterns and mode of detection: implications for the breast screening programme , 1998, Journal of medical screening.
[27] A. Miller,et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.
[28] N. Boyd,et al. The quantitative analysis of mammographic densities. , 1994, Physics in medicine and biology.
[29] J. Grove,et al. Factors associated with mammographic pattern. , 1985, The British journal of radiology.
[30] J. Grove,et al. Factors associated with breast structure in breast cancer patients , 1979, Cancer.